Rajkomar Kheman, Kweon Michelle, Khan Imran, Frankish Paul, Rodgers Michael, Koea Jonathan B
Kheman Rajkomar, Michelle Kweon, Michael Rodgers, Jonathan B Koea, the Department of Surgery, North Shore Hospital, Private Bag 93503,Takapuna, Auckland, New Zealand.
World J Gastrointest Endosc. 2017 Apr 16;9(4):196-203. doi: 10.4253/wjge.v9.i4.196.
To review the role of multidisciplinary management in treating sporadic duodenal adenomas (SDA).
SDA managed at North Shore Hospital between 2009-2014 were entered into a prospective database. Pathology, endoscopic and surgical management as well as follow up were reviewed.
Twenty-eight patients (14 male: Median age 68 years) presented with SDA [18 were classified as non ampullary location (NA), 10 as ampullary location (A)]. All SDA were diagnosed on upper gastrointestinal endoscopy and were imaged with a contrast enhanced CT scan of the chest, abdomen and pelvis. Of the NA adenomas 14 were located in the second part, 2 in the first part and 2 in the third part of the duodenum. Two patients declined treatment, 3 patients underwent surgical resection (2 transduodenal resections and 1 pancreaticoduodenectomy), and 23 patients were treated with endoscopic mucosal resection (EMR). The only complication with endoscopic resection was mild pancreatitis post procedure. Patients were followed with gastroduodenoscopy for a median of 22 mo (range: 2-69 mo). There were 8 recurrences treated with EMR with one patient proceeding to pancreaticodeuodenectomy because of high grade dysplasia in the resected specimen and 2 NA recurrences were managed with surgical resection (distal gastrectomy for a lesion in the first part of the duodenum and a transduodenal resection of a lesion in the third part of the duodenum).
SDA can be treated endoscopically with minimal morbidity and piecemeal resection results in eradication in nearly three quarters of patients. Recurrent SDA can be treated with endoscopic reresection with surgical resection indicated when the lesions are large (> 4 cm in diameter) or demonstrate severe dysplasia or invasive cancer.
回顾多学科管理在治疗散发性十二指肠腺瘤(SDA)中的作用。
将2009年至2014年在北岸医院接受治疗的SDA患者纳入前瞻性数据库。对病理、内镜和手术管理以及随访情况进行回顾。
28例患者(14例男性,中位年龄68岁)患有SDA[18例被分类为非壶腹部位(NA),10例为壶腹部位(A)]。所有SDA均通过上消化道内镜诊断,并进行了胸部、腹部和盆腔的增强CT扫描成像。在NA腺瘤中,14例位于十二指肠第二部,2例位于第一部,2例位于第三部。2例患者拒绝治疗,3例患者接受了手术切除(2例经十二指肠切除术和1例胰十二指肠切除术),23例患者接受了内镜黏膜切除术(EMR)。内镜切除的唯一并发症是术后轻度胰腺炎。患者接受胃十二指肠镜随访,中位时间为22个月(范围:2 - 69个月)。有8例复发患者接受了EMR治疗,1例患者因切除标本中存在高级别异型增生而接受了胰十二指肠切除术,2例NA复发患者接受了手术切除(十二指肠第一部病变行远端胃切除术,十二指肠第三部病变行经十二指肠切除术)。
SDA可以通过内镜治疗,发病率极低,且小块切除可使近四分之三的患者得到根治。复发性SDA可通过内镜再次切除治疗,当病变较大(直径>4 cm)或显示严重异型增生或浸润性癌时,则需进行手术切除。